Tofacitinib citrate CAS 540737-29-9

Identification

CAS Number

540737-29-9

Name

Tofacitinib citrate

Synonyms

(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile citrate salt
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt) [ACD/Index Name]
2-Hydroxy-1,2,3-propantricarbonsäure –3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropannitril (1:1) [German] [ACD/IUPAC Name]
3-[(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile citrate salt
3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile 2-hydroxy-1,2,3-propanetricarboxylate (1:1) [ACD/IUPAC Name]
540737-29-9 [RN]
Acide 2-hydroxy-1,2,3-propanetricarboxylique – 3-{(3R,4R)-4-méthyl-3-[méthyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-pipéridinyl}-3-oxopropanenitrile (1:1) [French] [ACD/IUPAC Name]
MFCD11616529 [MDL number]
Tasocitinib citrate salt
Tofacitinib citrate [USAN]
[540737-29-9]
1259404-17-5 [RN]
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-??-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ß-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
2-hydroxy-1,2,3-propanetricarboxylate-4-methyl-3R-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4R-ylamino)-?-oxo-1-piperidinepropanenitrile
2-hydroxy-1,2,3-propanetricarboxylate-4-methyl-3R-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4R-ylamino)-β-oxo-1-piperidinepropanenitrile
2-hydroxypropane-1,2,3-tricarboxylic acid
2-hydroxypropane-1,2,3-tricarboxylic acid and 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
3-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino) piperidin-1-yl)-3-oxopropanenitrile citric acid
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate
4-Methoxy-7-nitroindolinyl-caged-L-glutamate | MNI glutamate |
CITRIC ACID; TOFACITINIB
CP 690,550
CP 690550-10
CP-690550 (Tofacitinib citrate)
CP690550 citrate
CP-690550 citrate
CP-690550 Citrate (Tofacitinib Citrate)
MFCD23703608 [MDL number]
Not available
racemic Tasocitinib
Tasocitinib citrate
Tasocitinib citrate;CP-690550 citrate;CP 690550 citrate;CP690550 citrate
Tasocitinib citric acid salt
Tofacitinib (citrate)
Tofacitinib (CP-690550) Citrate
Tofacitinib citrate (CP-690550 citrate)
Tofacitinib citrate
TOFACITINIB CITRATE SALT
tofacitinib citrate(cp690550)
UNII:O1FF4DIV0D
Xeljanz [Trade name]

Molecular Structure

Structure of Tofacitinib citrate CAS 540737-29-9

SMILES

C[[email protected]@H]1CCN(C[[email protected]@H]1N(C)c2c3cc[nH]c3ncn2)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

StdInChI

InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1

StdInChIKey

SYIKUFDOYJFGBQ-YLAFAASESA-N

Molecular Formula

C16H20N6O · C6H8O7

Molecular Weight

504.49

MDL Number

MFCD11616529

Properties

Appearance

White to off-white crystalline powder

Safety Data

RIDADR 

NONH for all modes of transport

WGK Germany

3

Specifications and Other Information of Our Tofacitinib citrate CAS 540737-29-9

Identification Methods

HPLC;IR

Assay

98%~102%

Citric acid

36.2%~40%

TOFT-IMI

≤0.15%

TOFI-IME

≤0.15%

TOFT-IMK

≤0.15%

TOFI-IMO

≤0.15%

Single Unspecified Impurity

≤0.10%

Total Impurities

≤0.5%

Loss on Drying

≤0.5%

Residue on Ignition

≤0.1%

Enantiomer: TOFT-IMF

≤0.15%

Methanol

≤3000ppm

Ethanol

≤5000ppm

Isopropanol

≤5000ppm

Toluene

≤890ppm

Ethyl cyanoacetate

≤1000ppm

Shelf Life

1 year

Storage

Under room temperature away from light

Known Application

Often used to treat rheumatoid arthritis.

This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details. http://www.caming.com/tofacitinib-citrate-cas-540737-29-9/ This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details. http://www.watson-int.com/tofacitinib-citrate-cas-540737-29-9/
Posted in APIs, Caming Pharmaceutical Ltd, Products